Presinol en es it fr

Presinol Brand names, Presinol Analogs

Presinol Brand Names Mixture

  • No information avaliable

Presinol Chemical_Formula


Presinol RX_link

Presinol fda sheet

Presinol FDA

Presinol msds (material safety sheet)

Presinol MSDS

Presinol Synthesis Reference

No information avaliable

Presinol Molecular Weight

1270.28 g/mol

Presinol Melting Point

No information avaliable

Presinol H2O Solubility

Freely soluble as sodium salt (> 200mg/mL)

Presinol State


Presinol LogP

No information avaliable

Presinol Dosage Forms

Powder for solution (for injection)

Presinol Indication

For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Presinol Pharmacology

Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.

Presinol Absorption

No information avaliable

Presinol side effects and Toxicity

Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.

Presinol Patient Information

No information avaliable

Presinol Organisms Affected

Aspergillis, Candida and other fungi